Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Afica. Significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection

Archives of Internal Medicine

Volumn 160, Issue 21, 2000, Pages 3286-3293

  Andersson, S ^a   Norrgren, H ^a   Da Silva, Z ^a   Biague, A ^a   Bamba, S ^a   Kwok, S ^a   Christopherson, C ^a   Biberfeld, G ^a   Albert, J ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; AFRICA; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; VIRUS LOAD;

EID: 0034722743     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.21.3286     Document Type: Article

References (46)

1. Reduced rate of disease development after HIV-2 infection as compared to HIV-1
2. Slower heterosexual spread of HIV-2 than HIV-1
3. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau
4. Epidemiology and transmission of HIV-2: Why there is no HIV-2 pandemic
5. HIV viral load markers in clinical practice
6. + lyrnphocytes as prognostic markers of HIV-1 infection
7. A simple relationship between viral load and survival time in HIV-1 infection
8. Biological and virologic characteristics of primary HIV infection
9. Cellular and plasma viral load in patients infected with HIV-2
10. A community-based study of human immunodeficiency virus type 2 provirus load in a rural village in West Africa
11. HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau
12. + lymphopenia in HIV type 2 infected individuals
13. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection
14. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2
15. Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, West Africa: No protection of HIV-2 against HIV-1 infection
16. HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: Incidence, prevalence and HIV-2 associated mortality in an occupational cohort in Guinea-Bissau
17. Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2 prevalent area
18. A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II and HTLV-IIIB
19. Cross-reactivity on Western blots in HIV-1 and HIV-2 infections
20. Proposed WHO criteria for interpretation of results from Western blot assay for HIV-1, HIV-2 and HTLV-I/HTLV-II
21. High concordance between polymerase chain reaction and antibody testing of specimens from HIV-1 and HIV-2 dually infected individuals in Guinea-Bissau, West Africa
22. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1- in plasma: Application to acute retroviral infection
23. HIV viral dynamics
24. Molecular characterization of HIV-1 and HIV-2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa
25. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
26. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
27. Hemophilia and nonprogressing human immunodeficiency virus type 1 infection
28. HIV-2 as a model for long term non-progression
29. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection
30. + lymphocyte count differs in monotypic and dual HIV infections
31. Reduction of HIV concentration during acute infection: Independence from a specific immune response
32. Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virustype 1 RNA load suppression by zidovudine
33. HIV-1 and HIV-2 dual infection: Lack of HIV-2 provirus with low CD4+ Lymphocyte counts
34. Natural protection against HIV-1 infection provided by HIV-2
35. Lack of protection against HIV-1 infection among women with HIV-2 infection
36. Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequence subtypes with differences in virus biology
37. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
38. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease
39. Virologic and serologic characteristics of a natural chimpanzee lentivirus infection
40. 1992 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
41. WHO case definitions for AIDS surveillance in adults and adolescents
42. Subtype-specific problems with quantification of plasma HIV-1 RNA
43. Assay of plasma samples representing different genetic subtypes: An evaluation of new versions of the Amplicor HIV-1 Monitor assay
44. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1, and the performance of an improved AMPLICOR HIV-1 MONITOR test on diverse subtypes
45. Variable reactivity of genetic HIV-2 subtypes in a prototype PCR-based vRNA quantitative assay